ELUT ELUTIA INC.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $36.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $1.2K | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $4.0M | $0 |
| 2023-Q1 | $206.8K | $1.2K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $1.0M | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $109.9K | $0 |
| 2026-Q1 | $126.8K | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$7.3M29 buy days
Sold$1.2K1 sell day
Net insider flow+$7.3Mnet buying · 5 years
Latest trade2026-01-30RAKIN KEVIN
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-01-30 | Buy | RAKIN KEVIN | Director | 70,000 | $1.06 | $74.2K | 1 |
| 2026-01-30 | Buy | NEELS GUIDO J | Director | 20,000 | $1.04 | $20.8K | 1 |
| 2026-01-29 | Buy | NEELS GUIDO J | Director | 15,000 | $1.06 | $15.9K | 1 |
| 2026-01-28 | Buy | NEELS GUIDO J | Director | 15,000 | $1.06 | $15.9K | 1 |
| 2025-12-17 | Buy | Ferguson Matthew | CFO | 60,000 | $0.53 | $31.8K | 1 |
| 2025-12-17 | Buy | RAKIN KEVIN | Director | 50,000 | $0.52 | $26.0K | 1 |
| 2025-12-17 | Buy | Makes Brigid | Director | 25,000 | $0.52 | $13.0K | 1 |
| 2025-12-17 | Buy | Colpman David | Director | 12,500 | $0.51 | $6.4K | 1 |
| 2025-12-17 | Buy | Mills C Randal | CEO | 3,000 | $0.51 | $1.5K | 1 |
| 2025-12-02 | Buy | Ferguson Matthew | CFO | 5,500 | $0.67 | $3.7K | 1 |
| 2025-12-01 | Buy | Ferguson Matthew | CFO | 4,500 | $0.65 | $2.9K | 1 |
| 2025-11-24 | Buy | Mills C Randal | CEO | 5,000 | $0.60 | $3.0K | 1 |
| 2025-11-17 | Buy | Colpman David | Director | 15,500 | $0.74 | $11.5K | 1 |
| 2025-11-13 | Buy | Mills C Randal | CEO | 13,500 | $0.75 | $10.1K | 3 |
| 2025-02-03 | Buy | HighCape Capital, L.P. | Director | 420,000 | $2.50 | $1.0M | 1 |
| 2023-03-27 | Buy | Strobeck Matthew | Other | 10,000 | $1.59 | $15.9K | 1 |
| 2023-03-24 | Buy | Strobeck Matthew | Other | 20,000 | $1.35 | $27.0K | 2 |
| 2023-03-23 | Buy | Strobeck Matthew | Other | 110,000 | $1.49 | $163.9K | 2 |
| 2023-03-09 | Sell | Englese Thomas | Other C-suite | 289 | $4.30 | $1.2K | 1 |
| 2022-12-15 | Buy | Colpman David | Director | 3,098 | $3.90 | $12.1K | 1 |
| 2022-12-09 | Buy | Makes Brigid | Director | 2,000 | $3.65 | $7.3K | 1 |
| 2022-12-08 | Buy | Strobeck Matthew | 10% owner | 13,061 | $3.79 | $49.5K | 2 |
| 2022-12-07 | Buy | Strobeck Matthew | 10% owner | 44,000 | $3.58 | $157.5K | 2 |
| 2022-12-05 | Buy | RAKIN KEVIN | Director | 735,000 | $4.75 | $3.5M | 1 |
| 2022-12-05 | Buy | Ferguson Matthew | CFO | 22,000 | $4.65 | $102.2K | 2 |
| 2022-12-02 | Buy | Ferguson Matthew | CFO | 6,000 | $4.03 | $24.2K | 1 |
| 2022-12-01 | Buy | Strobeck Matthew | 10% owner | 40,000 | $4.75 | $190.0K | 1 |
| 2022-05-11 | Buy | Strobeck Matthew | 10% owner | 200 | $5.96 | $1.2K | 1 |
| 2021-12-14 | Buy | Englese Thomas | Other C-suite | 4,580 | $6.10 | $27.9K | 1 |
| 2021-12-08 | Buy | RAKIN KEVIN | Director | 412,735 | $4.24 | $1.7M | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| RAKIN KEVIN | Director | $6.4M | $0 | 2026-01-30 |
| Strobeck Matthew | Other | $605.0K | $0 | 2023-03-27 |
| Ferguson Matthew | CFO | $164.8K | $0 | 2025-12-17 |
| NEELS GUIDO J | Director | $52.6K | $0 | 2026-01-30 |
| Colpman David | Director | $29.9K | $0 | 2025-12-17 |
| Englese Thomas | Other C-suite | $27.9K | $1.2K | 2023-03-09 |
| Makes Brigid | Director | $20.3K | $0 | 2025-12-17 |
| Mills C Randal | CEO | $14.6K | $0 | 2025-12-17 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2025-11-13 → 2025-12-17 | 5 | $109.9K | 54 | -13.6% (-12.3% raw) | +56.6% (+55.7% raw) | +33.7% (+42.7% raw) | closed |
| 2022-12-01 → 2022-12-15 | 5 | $4.0M | 57 | +4.0% (+1.6% raw) | +12.9% (+9.9% raw) | -47.5% (-38.7% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.